Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D000328:Adult; D000616:Aminoglutethimide / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002247:Carbon Isotopes; D003480:Cushing Syndrome / Q000188:drug therapy*; D003632:Dichlorodiphenyldichloroethane / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010912:Pituitary-Adrenal Function Tests
D000927:Anticonvulsants; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D000616:Aminoglutethimide; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone